Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City (NCT07673380)
Leveraging mHealth to Promote Recovery From Opioid Use Disorder and Commonly Occurring Mental Health Disorders Among Residents of a Medium-Sized Midwestern City
🩺 Plain-English Summary (8th-Grade Level)
The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or stimulants.
Who can join: Review the eligibility criteria below.
Location: Washington University School of Medicine — St Louis, Missouri
Age range: 18 Years
🧪 Interventions in This Study
- uMAT-R + enhanced community engagement (BEHAVIORAL)
- Original uMAT-R supplementary mHealth recovery intervention (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Washington University School of Medicine — St Louis, Missouri
📞 Contact the Study Coordinator
Phone: (917) 836-4225
Email: szlyk@wustl.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid Use
- Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse — Raleigh, North Carolina
- Treating Polysubstance Use Using a Novel Digital Technology — Baltimore, Maryland
- Opioid Analgesic Reduction Study — Chicago, Illinois
- Patient Utilization of Opioid Destruction Bags in the Post-op Period — Omaha, Nebraska
- Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure — Chicago, Illinois
- SLeep and OPioid UsE in Patients Undergoing Total Knee Arthroplasty — La Jolla, California
Explore by condition: All Opioid Use clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.